Public health
fromwww.mediaite.com
1 day agoTrump FDA Official Warns Recent Changes at Agency Risk Public Health: Report
Richard Pazdur warned that Makary's accelerated drug-approval initiatives and expedited review program risk public health, legal compliance, and transparent scientific review.